Table 1.
Potency | Types | Advantages | Disadvantages |
---|---|---|---|
Pluripotent stem cells | ESCs | Indefinite self-renewal Multiple cell/tissue lineages | Ethical concerns Tumorigenicity Immune rejection |
IPSCs | Autologous Indefinite self-renewal | Tumorigenicity Cellular reprogramming | |
Mesenchymal stem cells | – | Autologous Abundant Easily accessible/harvested |
Donor site morbidity |
Chondrocytes | Fetal | Low immunogenicity | Limited availability |
Neonatal | Low immunogenicity | Limited availability | |
Juvenile | Low immunogenicity | Limited availability | |
Adult | Autologous | Limited availability Donor site morbidity De-differentiation |
ESC, Embryonic stem cell; IPSC, Induced pluripotent stem cells.